# Air Pollution and Cardiovascular Disease in Qatar: an Interventional Study to Reduce Blood Pressure

Study · id `cardio:ct-nct05903950` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05903950](<https://clinicaltrials.gov/study/NCT05903950>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05903950

Browse, organ or system: Blood vessels; Metabolism  
Browse, condition area: High blood pressure; Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.

## Technical summary

Registry record NCT05903950. Randomized; triple masking; primary purpose prevention. Start 2024-11-03 (actual); primary completion 2026-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT05903950, source copy `cardio:ctgov-nct05903950-2026-10-23`, retrieved 2026-10-26)
- Started: 2024-11-03 (actual) (ClinicalTrials.gov record NCT05903950, source copy `cardio:ctgov-nct05903950-2026-10-23`, retrieved 2026-10-26)
- Primary completion: 2026-12 (anticipated) (ClinicalTrials.gov record NCT05903950, source copy `cardio:ctgov-nct05903950-2026-10-23`, retrieved 2026-10-26)
- Completion: 2026-12 (anticipated) (ClinicalTrials.gov record NCT05903950, source copy `cardio:ctgov-nct05903950-2026-10-23`, retrieved 2026-10-26)
- Countries: Qatar (ClinicalTrials.gov record NCT05903950, source copy `cardio:ctgov-nct05903950-2026-10-23`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05903950-2026-10-23`, retrieved 2026-10-26)

## The registry's words

- Brief title: Air Pollution and Cardiovascular Disease in Qatar: an Interventional Study to Reduce Blood Pressure
- Acronym: APCIQ-BP
- Condition: Hypertension, Systolic
- Condition: Metabolic Syndrome
- Condition: Typ 2 Diabetes
- Intervention (Device): Air cleaners with HEPA filter
- Intervention (Device): Air cleaners without HEPA filter
- Lead sponsor: Weill Cornell Medical College in Qatar
- Lead sponsor class: OTHER
- Collaborator: Hamad Medical Corporation
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Metabolic syndrome (`cardio:metabolic-syndrome`)
- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry condition terms include this condition: Diabetes mellitus (`core:diabetes-mellitus`)
- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: Weill Cornell Medical College in Qatar (`cardio:org-weill-cornell-medical-college-in-qatar`)
- Registry lists this organization as a collaborator: Hamad Medical Corporation (`cardio:org-hamad-medical-corporation`)

## Provenance

Content hash: a49591221dccabc899c1fda325222a3d992f1cef4d4e32d0dd706bb90f3a9f83
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
